Inventor · disambiguated record
Zhenkun Ma
Also filed as: MA ZHENKUN
41 granted patents·22 pending applications·613 citations·filing 1995–2023
98Inventor score
Files withABBOTT LAB20CUMBRE PHARMACEUTICALS INC8TENNOR THERAPEUTICS LTD5TENNOR THERAPEUTICS SUZHOU LTD5MA ZHENKUN3
Top patents by PatentIndex Score
63 records- 0195US5866549A6-O-substituted ketolides having antibacterial activityABBOTT LAB·Filed 1997·Granted Feb 2, 1999·176 cites·14 claims
- 0288US5599816AQuinolizinone type compoundsABBOTT LAB·Filed 1995·Granted Feb 4, 1997·41 cites·31 claims
- 0386US6420535B16-O-carbamate ketolide derivativesABBOTT LAB·Filed 2000·Granted Jul 16, 2002·35 cites·14 claims
- 0485US7238694B2Rifamycin imino derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 3, 2007·6 cites·51 claims
- 0585US6946446B2Anti-infective agents useful against multidrug-resistant strains of bacteriaABBOTT LAB·Filed 2001·Granted Sep 20, 2005·21 cites·20 claims
- 0682US6075133A6-O-substituted antibacterial erythromycin ketolides and methods of makingABBOTT LAB·Filed 1998·Granted Jun 13, 2000·43 cites·12 claims
- 0782US6054435A6-O-substituted macrolides having antibacterial activityABBOTT LAB·Filed 1999·Granted Apr 25, 2000·74 cites·14 claims
- 0881US10508097B2Antibacterial compounds and uses thereofGLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC·Filed 2017·Granted Dec 17, 2019·2 cites·24 claims
- 0980US6028181A6-0-Substituted antibacterial erythromycin ketolides and methods of makingABBOTT LAB·Filed 1998·Granted Feb 22, 2000·36 cites·9 claims
- 1078US7678791B2Nitroheteroaryl-containing rifamycin derivativesCUMBRE IP VENTURES L P·Filed 2007·Granted Mar 16, 2010·4 cites·7 claims
- 1177US7265107B2Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Sep 4, 2007·3 cites·27 claims
- 1277US7202246B2Spiro-rifamycin derivatives targeting RNA polymeraseCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Apr 10, 2007·3 cites·34 claims
- 1375US6355620B1C-2 modified erythromycin derivativesABBOTT LAB·Filed 1999·Granted Mar 12, 2002·38 cites·13 claims
- 1474US7247634B2Rifamycin derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 24, 2007·3 cites·53 claims
- 1573US7250413B2C-25 carbamate rifamycin derivatives with activity against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 31, 2007·1 cites·18 claims
- 1671US7666864B2Bicyclic nitroimidazole-substituted phenyl oxazolidinonesGLOBAL ALLIANCE FOR TB DRUG DE·Filed 2009·Granted Feb 23, 2010·3 cites·15 claims
- 1771US7229996B2Rifamycin derivativesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 12, 2007·1 cites·8 claims
- 1871US7226931B2(R/S) rifamycin derivatives, their preparations and pharmaceutical compositionsCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 5, 2007·1 cites·15 claims
- 1971US6569836B26-O-alkyl-2-nor-2-substituted ketolide derivativesABBOTT LAB·Filed 2000·Granted May 27, 2003·4 cites·12 claims
- 2071US6034069A3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activityABBOTT LAB·Filed 1998·Granted Mar 7, 2000·28 cites·15 claims
- 2170US6075011A6-O-substituted erythromycin compounds and method for making sameABBOTT LAB·Filed 1997·Granted Jun 13, 2000·30 cites·29 claims
- 2269US6933283B211-deoxy azalide antibacterialsABBOTT LAB·Filed 2003·Granted Aug 23, 2005·3 cites·17 claims
- 2369US5726182AQuinolizinone type compoundsABBOTT LAB·Filed 1995·Granted Mar 10, 1998·12 cites·11 claims
- 2468USRE39591E6-O-substituted ketolides having antibacterial activityABBOTT LAB·Filed 2004·Granted Apr 24, 2007·2 cites·19 claims
- 2568US6764996B19a-azalides with antibacterial activityABBOTT LAB·Filed 2000·Granted Jul 20, 2004·4 cites·19 claims
- 2667US6667338B29-amino erythromycin derivatives with antibacterial activityABBOTT LAB·Filed 2002·Granted Dec 23, 2003·2 cites·21 claims
- 2765US8293734B2Nitroimidazooxazine and nitroimidazooxazole analogues and their usesTHOMPSON ANDREW MARK·Filed 2010·Granted Oct 23, 2012·2 cites·6 claims
- 2864US6992069B2Tricyclic macrolide antibacterial compoundsGU YU-GUI·Filed 2003·Granted Jan 31, 2006·2 cites·22 claims
- 2964US5618949AProcess for synthesis of chiral cis- and trans-3-amino-4-substituted pyrrolidine compoundsABBOTT LAB·Filed 1996·Granted Apr 8, 1997·9 cites·9 claims
- 3063US6147197A6-O-substituted erythromycin ketolides having antibacterial activityFiled 1998·Granted Nov 14, 2000·14 cites·4 claims
- 3162US10981891B2Antibacterial compounds and uses thereofGLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC·Filed 2019·Granted Apr 20, 2021·0 cites·15 claims
- 3260US6998390B2Oxolide antibacterialsMA ZHENKUN·Filed 2003·Granted Feb 14, 2006·2 cites·18 claims
- 3360US6831068B2Macrolide antibacterial compoundsABBOTT LAB·Filed 2003·Granted Dec 14, 2004·1 cites·6 claims
- 3460US5668164AProcess for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compoundsABBOTT LAB·Filed 1996·Granted Sep 16, 1997·6 cites·2 claims
- 3555US2024000755A1Pharmaceutical composition comprising sulbactam and avibactam, and application thereofTENNOR THERAPEUTICS SUZHOU LTD·Filed 2023·Application pending·0 cites
- 3654US8163769B2Antibacterial compoundsANDERSON DAVID·Filed 2003·Granted Apr 24, 2012·1 cites·19 claims
- 3752US12005050B2Methods for preventing or treating H. pylori infectionTENNOR THERAPEUTICS SUZHOU LTD·Filed 2023·Granted Jun 11, 2024·0 cites·14 claims
- 3852US2004033970A1Antibacterial compounds with improved pharmacokinetic profilesFiled 2003·Application pending·0 cites
- 3950US2014243327A1Riminophenazines with 2-(heteroaryl) amino substituents and their anti-microbial activityGLOBAL ALLIANCE FOR TB DRUG DEV·Filed 2014·Application pending·0 cites
- 4049US8716292B2Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activityLIU KAI·Filed 2011·Granted May 6, 2014·0 cites·7 claims
- 4148US2004014691A19-Oxime macrolide antibacterialsSEARLE XENIA BEEBE·Filed 2003·Application pending·0 cites
- 4248US2004014687A1Macrolide antibacterial compoundsFiled 2003·Application pending·0 cites
- 4347US7256187B2Rifamycin C-11 oxime derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Aug 14, 2007·0 cites·45 claims
- 4444US2020360352A1Use of rifamycin-nitroimidazole coupling moleculeTENNOR THERAPEUTICS SUZHOU LTD·Filed 2019·Application pending·0 cites
- 4544US2003207820A1Antibacterial compounds with improved pharmacokinetic profilesFiled 2002·Application pending·0 cites
- 4644US2021338645A1Solid dispersion of rifamycin-nitroimidazole coupling molecule and application thereofTENNOR THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4743US2003162729A1Macrolides with activity against methicillin-resistant staphylococcus aureusFiled 2002·Application pending·0 cites
- 4843US2002132782A19-amino erythromycin derivatives with antibacterial activityFiled 2001·Application pending·0 cites
- 4943US2004009932A1Antibacterial compounds with activity against penicillin-resistant streptococcus pneumoniaePHELAN KATHLEEN·Filed 2003·Application pending·0 cites
- 5042US2002193320A1C-2 modified erythromycin derivativesFiled 2000·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhenkun Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →